Literature DB >> 24690072

Late and long-term effects of breast cancer treatment and surveillance management for the general practitioner.

Megan Kenyon, Deborah K Mayer, Anna Kate Owens.   

Abstract

OBJECTIVE: To examine the most common long-term and late effects of breast cancer treatment, the American Society of Clinical Oncology guidelines for surveillance, and recommendations for the primary care provider's role in delivering breast cancer survivorship care. DATA SOURCES: A comprehensive literature review was conducted using CINAHL, PubMed, Google Scholar, and hand searches using the search terms breast cancer, survivor, and long-term or late effects. STUDY SELECTION: Articles published in English from 2002 to 2012 that addressed the long-term or late effects of adults with breast cancer were included. DATA EXTRACTION: Findings are discussed categorically, including the most common late and long-term psychosocial effects from relevant studies. DATA SYNTHESIS: Topics relevant to survivors included challenges to psychosocial, emotional, and cognitive well-being; satisfaction with life; sexuality; body image; anxiety; fear of recurrence and post-traumatic stress disorder; depression; cognitive dysfunction challenges to physical well-being; adverse cardiovascular events; fatigue; lymphedema; musculoskeletal symptoms; accelerated bone loss and fractures; pain; skin changes due to radiation; disease recurrence; and new breast cancers.
CONCLUSIONS: With earlier detection methods and improvements in treatment options making breast cancer a highly survivable disease, there are more survivors of breast cancer than ever. The clinicians' role in survivorship care is more important than ever to manage the potential long-term and late effects of treatment, physical and emotional well-being, and recurrent disease surveillance. However, the clinician's role in cancer follow-up care is often poorly defined leading to a lack of awareness about the needs of survivors of breast cancer, suboptimal communication between providers and survivors, and an overall deficiency in quality care.
© 2014 AWHONN, the Association of Women's Health, Obstetric and Neonatal Nurses.

Entities:  

Keywords:  breast cancer; breast cancer survivorship; late effects of treatment; long-term effects of treatment; primary care provider and breast cancer follow-up care

Mesh:

Year:  2014        PMID: 24690072     DOI: 10.1111/1552-6909.12300

Source DB:  PubMed          Journal:  J Obstet Gynecol Neonatal Nurs        ISSN: 0090-0311


  35 in total

1.  Aromatase inhibitor associated arthralgia: the importance of oncology provider-patient communication about side effects and potential management through physical activity.

Authors:  Kirsten A Nyrop; Leigh F Callahan; Christine Rini; Mary Altpeter; Betsy Hackney; Amy DePue; Anne Wilson; Arielle Schechter; Hyman B Muss
Journal:  Support Care Cancer       Date:  2016-01-12       Impact factor: 3.603

2.  Validation of the long-term quality of life breast cancer scale (LTQOL-BC) by health care professionals.

Authors:  Christine Ecclestone; Sunil Verma; Angela Leahey; Gillian Bedard; Julia Hamer; Eileen Rakovitch; Natalie Pulenzas; Anchal Bhatia; Carlo DeAngelis; Janet Ellis; Edward Chow
Journal:  Support Care Cancer       Date:  2014-11-23       Impact factor: 3.603

3.  Examination of Broad Symptom Improvement Resulting From Mindfulness-Based Stress Reduction in Breast Cancer Survivors: A Randomized Controlled Trial.

Authors:  Cecile A Lengacher; Richard R Reich; Carly L Paterson; Sophia Ramesar; Jong Y Park; Carissa Alinat; Versie Johnson-Mallard; Manolete Moscoso; Pinky Budhrani-Shani; Branko Miladinovic; Paul B Jacobsen; Charles E Cox; Matthew Goodman; Kevin E Kip
Journal:  J Clin Oncol       Date:  2016-05-31       Impact factor: 44.544

4.  Identifying the unmet needs of breast cancer patients post-primary treatment: the Cancer Survivor Profile (CSPro).

Authors:  Briana L Todd; Michael Feuerstein; Amanda Gehrke; Jennifer Hydeman; Lynda Beaupin
Journal:  J Cancer Surviv       Date:  2015-03-29       Impact factor: 4.442

5.  Who is managing menopausal symptoms, sexual problems, mood and sleep disturbance after breast cancer and is it working? Findings from a large community-based survey of breast cancer survivors.

Authors:  Michelle Peate; Christobel Saunders; Paul Cohen; Martha Hickey
Journal:  Breast Cancer Res Treat       Date:  2021-02-11       Impact factor: 4.872

6.  Recruitment of breast cancer survivors and their caregivers: implications for dyad research and practice.

Authors:  Angela Robertson Bazzi; Melissa A Clark; Michael Winter; Yorghos Tripodis; Ulrike Boehmer
Journal:  Transl Behav Med       Date:  2017-06       Impact factor: 3.046

7.  Fear of cancer recurrence in survivor and caregiver dyads: differences by sexual orientation and how dyad members influence each other.

Authors:  Ulrike Boehmer; Yorghos Tripodis; Angela R Bazzi; Michael Winter; Melissa A Clark
Journal:  J Cancer Surviv       Date:  2016-02-22       Impact factor: 4.442

8.  A Randomized Controlled Trial of the Effects of Mindfulness-Based Stress Reduction (MBSR[BC]) on Levels of Inflammatory Biomarkers Among Recovering Breast Cancer Survivors.

Authors:  Richard R Reich; Cecile A Lengacher; Thomas W Klein; Cathy Newton; Steve Shivers; Sophia Ramesar; Carissa B Alinat; Carly Paterson; Alice Le; Jong Y Park; Versie Johnson-Mallard; Maya Elias; Manolete Moscoso; Matthew Goodman; Kevin E Kip
Journal:  Biol Res Nurs       Date:  2017-05-01       Impact factor: 2.522

9.  Follow-up care practices and barriers to breast cancer survivorship: perspectives from Asian oncology practitioners.

Authors:  Terence Ng; Ming Ren Toh; Yin Ting Cheung; Alexandre Chan
Journal:  Support Care Cancer       Date:  2015-03-21       Impact factor: 3.603

10.  Factors associated with depressive symptoms in young long-term breast cancer survivors.

Authors:  Andrea A Cohee; Timothy Stump; Rebecca N Adams; Shelley A Johns; Diane Von Ah; Kathleen Zoppi; Betsy Fife; Patrick O Monahan; David Cella; Victoria L Champion
Journal:  Qual Life Res       Date:  2016-02-16       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.